¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Immunodeficiency with increased immunoglobulin M"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® immunoglobulin ÇÑ±Û ¸é¿ª±Û·ÎºÒ¸°
¼³¸í   
  Ç÷û¼ººÐ Áß ¸é¿ª¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí, ¶Ç Ç×ü ÀÛ¿ëÀ» Çϴ ´Ü¹éÁúÀÇ ÃÑĪ. Ç×ü ÀÛ¿ëÀ̶õ Ç׿ø¿¡ ¼±ÅÃÀûÀ¸·Î ¹ÝÀÀÇϴ ±â´ÉÀε¥, ÀÌ ÀÛ¿ëÀ» Çϴ °ÍÀº ´ëºÎºÐ Àü±âÀ̵¿¹ýÀ¸·Î ³ª´­ °æ¿ì °¨¸¶ ¿µ¿ª¿¡ ¼ÓÇϹǷΠ°¨¸¶±Û·ÎºÒ¸°À̶ó°íµµ ÇÑ´Ù. ±âº»±¸Á¶´Â ºÐÀÚ·® ¾à 2¸¸ 3,000ÀÇ L»ç½½(°¡º­¿î »ç½½) ÇÑ ½Ö°ú 5¸¸~7¸¸ÀÇ H»ç½½(¹«°Å¿î »ç½½) ÇÑ ½ÖÀÌ S-S ´Ù¸®°Éħ¿¡ ÀÇÇØ °áÇյȠ°ÍÀÌ´Ù.
  
  ¸é¿ª±Û·ÎºÒ¸°
¿µ¹® acquired immunodeficiency syndrome ÇÑ±Û ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
¼³¸í   
  Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV)¿¡ ÀÇÇÏ¿© ¸é¿ª ¼¼Æ÷°¡ ÆÄ±«µÊÀ¸·Î½á ÀÎüÀÇ ¸é¿ª´É·ÂÀÌ ±Øµµ·Î ÀúÇϵǾ´¿øÃ¼¿¡ ´ëÇÏ¿© ¹«¹æºñ »óÅ¿¡ À̸£´Â º´. ¿¡ÀÌÁî ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â¸ç, 1981³â ¹Ì±¹¿¡¼­ Ã³À½ º¸°íµÇ¾ú´Ù. ÃÖÃÊ °¨¿°À¸·ÎºÎÅÍ Áõ»óÀÌ ³ªÅ¸³ª±â±îÁö´Â Æò±Õ 10³â Á¤µµ °É¸®¸ç »ç¸Á·üÀÌ ´ë´ÜÈ÷ ³ô´Ù. ¼ºÀû Á¢ÃË, ¿À¿° ÁÖ»ç±â »ç¿ë, ¿À¿° Ç÷¾× ¹× Ç÷¾× Á¦Á¦ »ç¿ë, ¿¡ÀÌÁî »ê¸ð·ÎºÎÅÍ ¼öÁ÷°¨¿° µûÀ§¿¡ ÀÇÇÏ¿© °¨¿°µÈ´Ù. °¨¿° ÈÄ Àϰú¼ºÀ¸·Î °¨±â¿Í °°Àº Áõ»óÀ» º¸À̸砹ÙÀÌ·¯½ºÇ÷ÁõÀ¸·Î µÇÁö¸¸ ¹ÙÀÌ·¯½º´Â °¨¼ÒµÇ°í 6~8ÁÖ ÈÄ¿¡´Â Ç×ü°¡ ¾ç¼ºÀ¸·Î µÈ´Ù. 6~10³â Á¤µµÀÇ ¹«ÁõÈļº º¸±Õ±â°£À» Áö³ª¼­ ¿¡ÀÌÁî°ü·ÃÁõÈıº(AIDS related syndrome)À¸·Î µÈ´Ù. ÀúÇ×·ÂÀÇ °¨¼Ò, ¸²ÇÁÀýºñ´ë, Ã¼Áß°¨¼Ò, ¹ß¿­, ¸¸¼º¼³»ç°¡ À̾îÁø´Ù. ±× ÈÄ ¿¡ÀÌÁî·Î µÇ¸ç, ÆóÆ÷ÀÚÃæÆó·Å µîÀÇ ¿øÃ溴, Ä­µð´Ù µîÀÇ Áø±ÕÁõ, Ç츣Æä½º¹ÙÀÌ·¯½º±º µîÀÇ ±âȸ°¨¿°ÀÌ À̾îÁø´Ù. ¶ÇÇÑ Ä«Æ÷½ÃÀ°Á¾, ¸²ÇÁÁ¾ µîÀ» º´¹ßÇØ¼­ »ç¸ÁÇÑ´Ù. ¹ÙÀÌ·¯½ºÀÇ ³úÁ¶Á÷³» Áõ½ÄÀ¸·Î Ä¡¸Å¸¦ ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. HIV-1Àº 10³â°£¿¡ »ç¸Á·üÀÌ 90%, HIV-2´Â 10%ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • increased parenchymal density
    ½ÇÁú¹ÐµµÁõ°¡, ½ÇÁúÀ½¿µÁõ°¡
  • increased pulse
    ¸Æ¹ÚÇ×Áø
  • acquired immunodeficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • combined immunodeficiency
    º¹Çո鿪°áÇÌ
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • human immunodeficiency virus-2
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º2
  • immunodeficiency
    ¸é¿ª°áÇÌ
  • immunodeficiency disease
    ¸é¿ª°áÇ̺´
  • severe combined immunodeficiency disease
    ÁßÁõº¹Çո鿪°áÇ̺´
  • cold-insoluble immunoglobulin
    ÇÑ·©ºÒ¿ë¸é¿ª±Û·ÎºÒ¸°
  • immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°
  • immunoglobulin A
    ¸é¿ª±Û·ÎºÒ¸°A
  • immunoglobulin adhesion receptor
    ¸é¿ª±Û·ÎºÒ¸°ºÎÂø¼ö¿ëü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • increased parenchymal density
    ½ÇÁú¹ÐµµÁõ°¡, ½ÇÁúÀ½¿µÁõ°¡
  • acquired immunodeficiency syndrome
    (¢¡AIDS) ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • increased pulse
    ¸Æ¹ÚÇ×Áø
  • acquired immunodeficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¸Å°³¸é¿ª°áÇÌÁõÈıº
  • combined immunodeficiency
    º¹Çո鿪°áÇÌ
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • immunodeficiency disease
    ¸é¿ª°áÇ̺´
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • immunodeficiency
    ¸é¿ª°áÇÌ
  • cold-insoluble immunoglobulin
    ÇÑ·©ºÒ¿ë¸é¿ª±Û·ÎºÒ¸°
  • immunoglobulin class
    ¸é¿ª±Û·ÎºÒ¸°°è
  • immunoglobulin cleavage
    ¸é¿ª±Û·ÎºÒ¸°ºÐÇÒ
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª
  • monoclonal immunoglobulin detection
    ´ÜÀÏŬ·Ð¸é¿ª±Û·ÎºÒ¸°°ËÃâ
  • immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • HIV => human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • HIV=>human immunodeficiency virus
    ÀÎü ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
  • Human immunodeficiency virus = HIV
    »ç¶÷¸é¿ª°áÇ̼º ¹ÙÀÌ·¯½º
  • acquired immunodeficiency syndorme
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº(ý­ô¸àõ Øóæ¹ÌÀù¹ ñøý¦ÏØ)
  • acquired immunodeficiency syndrome
    ÈÄõ¼º¸é¿ª°áÇÌÁõ
  • acquired immunodeficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acquired immunodeficiency syndrome (AIDS)
    ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
  • acquired immunodeficiency syndrome(AIDS)
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • huma immunodeficiency virus
    ÀÎü¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV)
  • huma immunodeficiency virus,fetal acquisition of
    Å»ýȹµæ(÷ÃßæüòÔð)
  • huma immunodeficiency virus,follicular dendritic cell infection by
    ¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
  • huma immunodeficiency virus,genome of
    °Ô³ð
  • huma immunodeficiency virus,virion of
    ºñ¸®¿Â
  • immunodeficiency
    ¸é¿ª°áÇÌ.
  • immunodeficiency
    ¸é¿ª°áÇÌ(Øóæ¹ÌÀù¹)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • edema,increased hydrostatic pressure
    ¼ö¾Ð Áõ°¡(â©äâ ñòÊ¥)
  • edema,increased osmotic pressure
    »ïÅõ¾Ð Áõ°¡(ß¶÷âäâ ñòÊ¥)
  • edema,increased vascular permeability
    Ç÷°üÅõ°ú¼ºÁõ°¡(úìη÷âΦàõñòÊ¥)
  • increased
    Áõ°¡µÈ
  • increased automatism
    ÀÚµ¿Ç×ÁøÁõ(í»ÔÑùñòäñø)
  • increased echogenicity
    Áõ°¡µÈ ¿¡ÄÚÀ½¿µ
  • increased intracranial pressure
    µÎ°³³»¾ÐÇ×Áø(ÔéËÏÒ®äâùñòä).
  • increased level
    Áõ°¡Ä¡
  • increased oxygenaffinity of hemoglobin
    Çì¸ð±Û·ÎºóÀÇ »ê¼Òģȭ¼º Áõ°¡.
  • increased pulse
    ¸Æ¹ÚÇ×Áø.
  • increased through transmission
    À½ÆÄ Åõ°ú¼º (ëå÷î ÷âΦàõ)ÀÌ Áõ°¡ (ñòÊ¥)µÈ
  • increased through transmission
    Áõ°¡µÈ À½ÆÄ Åõ°ú¼º
  • increased venous pressure
    Á¤¸Æ¾ÐÇ×Áø.
  • acquired immunodeficiency syndorme
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº(ý­ô¸àõ Øóæ¹ÌÀù¹ ñøý¦ÏØ)
  • acquired immunodeficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-immunoglobulin antibody
    Ç׸鿪(ù÷Øóæ¹)±Û·ÎºÒ¸° Ç×ü(ù÷ô÷)
  • immunoglobulin
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • immunoglobulin chain
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° »ç½½
  • immunoglobulin fold
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° Á¢±â
  • immunoglobulin gene
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° À¯ÀüÀÚ(ë¶îîí­)
  • 7S immunoglobulin
    7S ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • 19S immunoglobulin
    19S ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type I immunoglobulin
    IÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type II immunoglobulin
    IIÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type K immunoglobulin
    KÇü(úþ) ¸é¿ª(Øóæ¹) ±Û·ÎºÒ¸°
  • type L immunoglobulin
    LÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunodeficiency
    ¸é¿ª°áÇÌ
  • increased echogenicity
    Áõ°¡µÈ ¿¡ÄÚÀ½¿µ
  • increased intracranial pressure
    µÎ°³³»¾ÐÇ×Áø
  • increased through transmission
    Áõ°¡µÈ À½ÆÄ Åõ°ú¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
MIg malaria immunoglobulin; measles immunoglobulin; membrane immunoglobulin
CID cellular immunodeficiency; charge injection device; chick infective dose; combined immunodeficiency ...
ID identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ...
IDA   1) Imino-Diacetic Acid
  2) Iron Deficiency Anemia
   &nb...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HIV/AIDS Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Ca2+ C and increased
125I Increased
Na increased as
i Increased
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • D80.5
    Immunodeficiency with increased immunoglobulin M[IgM]
    ¸é¿ª±Û·ÎºÒ¸°MÀÇ Áõ°¡¸¦ µ¿¹ÝÇÑ ¸é¿ª°áÇÌÁõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • increased echogenicity
    Áõ°¡µÈ ¿¡ÄÚ À½¿µ
  • increased salivation
    Ÿ¾× ºÐºñ Áõ°¡
  • increased through transmission
    Áõ°¡µÈ À½ÆÄ Åõ°ú¼º
  • increased use of a muscle
    ±ÙÀ° »ç¿ëÀÇ Áõ°¡
  • acquired immunodeficiency
    ÈÄõ¼º ¸é¿ª°áÇÌ
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¼º ¸é¿ª °áÇÌ ÁõÈıº
  • combined immunodeficiency disease
    º¹ÇÕÇü ¸é¿ª °áÇÌ Áúȯ
  • human immunodeficiency virus
    Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º
  • human immunodeficiency virus infection
    Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º °¨¿°
  • immunodeficiency
    ¸é¿ª °áÇÌ
    ¸é¿ª ¹ÝÀÀÀÇ °áÇÌÀ¸·Î ÀÎÇÑ ¸é¿ª Àå¾Ö´Â Ç×ü[B ¼¼Æ÷] ¸é¿ª °áÇÌ, ¼¼Æ÷¼º [T ¼¼Æ÷} ¸é¿ª °áÇÌ, ÇÕº´Çü ¸é¿ª °áÇÌ ¹× ½Ä ÀÛ¿ë ±â´É Àå¾Ö·Î ºÐ·ùÇÑ´Ù. Ç×ü ¸é¿ª °áÇÌÀº Àú ȤÀº ÀÌ»ó °¨¸¶ ±Û·ÎºÒ¸°Ç÷Áõ, ¹Ýº¹¼º ¼¼±Õ¼º ÁßÀÌ¿° ¹× ºÎºñµ¿ Æó¼º °¨¿°Áõ µîÀÌ Æ¯Â¡ÀÌ´Ù. ¼¼Æ÷¼º ¸é¿ª °áÇÌÀº ±âȸ °¨¿°ÀÌ ÀÚÁÖ ÀϾ°í, ¼öÇ÷ ÈÄ ÀÌ½ÄÆí ´ë ¼÷ÁÖ ¹ÝÀÀ, »ý ¹é½Å ¸é¿ª Á¢Á¾ ÈÄ ½ÉÇÑ °¨¿°ÁõÀÇ ¹ß»ý µîÀÌ Æ¯Â¡ÀÌ´Ù. ½Ä ÀÛ¿ë ±â´É Àå¾Ö´Â ¿ÜÀμº°ú ³»Àμº ¿äÀÎÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. ¿ÜÀμº ¿äÀÎÀº ¸é¿ª ¾ïÁ¦Á¦¿¡ ÀÇÇÑ ½Ä ¼¼Æ÷ ¼öÀÇ °¨¼Ò ȤÀº ºÎ½Å ÇÇÁú ½ºÅ×·ÎÀ̵忡 ÀÇÇÑ ±â´É Àå¾Ö µîÀ̸ç, ³»Àμº ¿äÀÎÀº °ü·ÃµÈ È¿¼Ò °áÇÌ µîÀ» µé ¼ö ÀÖ´Ù. ½Ä ÀÛ¿ë ±â´É Àå¾Ö´Â °æ¹ÌÇÑ ¹Ýº¹¼º ÇǺΠ°¨¿°À¸·ÎºÎÅÍ Ä¡¸íÀûÀÎ Àü½Å¼º °¨¿°¿¡ À̸£±â±îÁö ¼¼±Õ EH´Â Áø±Õ¿¡ ÀÇÇÑ °¨¿°À» ¾ß±âÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ÇÕº´Çü ¸é¿ª °áÇÌÀº Ç×ü ¸é¿ªÀ» ¸Å°³ÇÏ´Â B ¸²ÇÁ±¸¿Í ¼¼Æ÷¼º ¸é¿ªÀ» ¸Å°³ÇÏ´Â T ¸²ÇÁ±¸°¡ °áÇ̵Ǿî ÀÖ´Ù.
  • severe combined immunodeficiency
    ÁßÁõ º¹ÇÕ ¸é¿ª °áÇÌÁõ, ÁßÁõ È¥ÇÕ ¸é¿ª °áÇÌÁõ
  • amylase complex with immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸° ¾Æ¹Ð¶óÁ¦ º¹ÇÕü
  • half-life of immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ¹Ý°¨±â
  • immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°
    µ¿ÀǾî=secretory IgA. 1. Ç×ü ±â´ÉÀ» °¡Áö°í ÀÖ°í ±¸Á¶ÀûÀ¸·Î ºñ½ÁÇÑ ´ç ´Ü¹éÀÇ ÃÑĪÀ̸ç, ±¸Á¶ ¹× »ý¹°ÇÐÀû Ȱ¼º¿¡ µû¶ó 5Á¾À¸·Î ±¸ºÐÇÑ´Ù. ¸é¿ª ±Û·ÎºÒ¸° ºÐÀÚÀÇ ±âº»ÀûÀÎ ±¸Á¶ ´ÜÀ§
  • immunoglobulin class
    ¸é¿ª ±Û·ÎºÒ¸° Ŭ¶ó½º
    Ç×ü ±â´ÉÀ» °¡Áö°í ÀÖ°í ±¸Á¶ÀûÀ¸·Î ºñ½ÁÇÑ ´ç ´Ü¹éÀÇ ±¸Á¶ ¹× »ý¹°ÇÐÀû Ȱ¼º¿¡ µû¸¥ 5Á¾ÀÇ Å¬¶ó½º. Áï IgM, IgG, IgA, IgD, IgE.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
cellular immunodeficiency with abnormal immunoglobulin synthesis An ill-defined group of sporadic disorders of unknown cause, occurring in both males and females and associated with recurrent bacterial, fungal, protozoal, and viral infections; there is thymic hypoplasia with depressed cellular (T-lymphocyte) immunity combined with defective humoral (B-lymphocyte) immunity, although immunoglobulin levels may be normal.
Synonym: Nezelof syndrome, Nezelof type of thymic alymphoplasia.
(05 Mar 2000)
increased markings emphysema A term applied to mixed obstructive lung disease in which radiographic findings of emphysema coexist with nonvascular shadows, probably related to bronchial inflammation.
(05 Mar 2000)
increased skull thickness <radiology> Generalised, chronic severe anaemia (e.g. Thalassaemia, SSD), cerebral atrophy following shunting of hydrocephalus, Engelmann disease: mainly skull base, hyperparathyroidism, acromegaly, osteopetrosis, chronic dilantin ingestion focal, meningioma, fibrous dysplasia, Dyke-Davidoff syndrome, hyperostosis frontalis interna, metastases
(12 Dec 1998)
interstitial lung disease with increased volume <radiology> Cystic fibrosis (CF), eosinophilic granuloma (EG), lymphangioleiomyomatosis (LAM)
(12 Dec 1998)
acquired immunodeficiency disease Acquired immunodeficiency disease: Disease caused by infection with the human immunodeficiency virus (HIV).
(12 Dec 1998)
Acquired Immunodeficiency Syndrome <immunology, syndrome> An epidemic disease caused by an infection by human immunodeficiency virus (HIV-1, HIV-2), a retrovirus that causes immune system failure and debilitation and is often accompanied by infections such as tuberculosis. AIDS is spread through direct contact with bodily fluids.
Acronym: AIDS
(10 May 1997)
bovine immunodeficiency virus A lentivirus causing lymphocytosis in cattle.
(05 Mar 2000)
malignancy and immunodeficiency <radiology> High risk of malignancy (especially lymphoma/leukaemia, GI tumours): X-linked agammaglobulinaemia (Bruton's), common variable immunodeficiency, severe combined immunodeficiency (SCID kids), ataxia-telangectasia, Wiscott-Aldrich syndrome, selective IgA deficiency
(12 Dec 1998)
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
phagocytic dysfunction immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
combined immunodeficiency <immunology> Congenital immunodeficiency with thymic agenesis, lymphocyte depletion and hypogammaglobulinaemia: both cellular and humoral immune systems are affected and life expectancy is low unless marrow transplantation is successful.
(18 Nov 1997)
combined immunodeficiency syndrome <syndrome> A serious primary immunodeficiency affecting both T and B-cells.
(05 Mar 2000)
common variable immunodeficiency Heterogeneous group of immunodeficiency syndromes characterised by hypogammaglobulinaemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.
(12 Dec 1998)
congenital severe combined immunodeficiency Disease, one form of which is caused by the lack of a transcription factor required for expression of HLA class II genes.
(18 Nov 1997)
murine acquired immunodeficiency syndrome <syndrome> Acquired defect of cellular immunity that occurs in mice infected with mouse leukaemia viruses (mulv). The syndrome shows striking similarities with human aids and is characterised by lymphadenopathy, profound immunosuppression, enhanced susceptibility to opportunistic infections, and B-cell lymphomas.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunodeficiency
    ¸é¿ª°á¿©(ºÎÀü) 9
  • immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á